1. Home
  2. BNT vs NBIX Comparison

BNT vs NBIX Comparison

Compare BNT & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Wealth Solutions Ltd.

BNT

Brookfield Wealth Solutions Ltd.

HOLD

Current Price

$45.73

Market Cap

11.8B

Sector

N/A

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.13

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNT
NBIX
Founded
2020
1992
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
13.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BNT
NBIX
Price
$45.73
$130.13
Analyst Decision
Strong Buy
Analyst Count
0
22
Target Price
N/A
$180.82
AVG Volume (30 Days)
28.3K
901.1K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
0.64%
N/A
EPS Growth
N/A
41.95
EPS
N/A
4.67
Revenue
N/A
$161,626,000.00
Revenue This Year
N/A
$22.85
Revenue Next Year
N/A
$10.36
P/E Ratio
$19.14
$27.09
Revenue Growth
N/A
977.51
52 Week Low
$40.06
$97.30
52 Week High
$74.16
$160.18

Technical Indicators

Market Signals
Indicator
BNT
NBIX
Relative Strength Index (RSI) 66.64 50.14
Support Level $44.62 $124.29
Resistance Level $47.53 $136.23
Average True Range (ATR) 1.10 4.29
MACD 0.56 -0.08
Stochastic Oscillator 97.72 59.64

Price Performance

Historical Comparison
BNT
NBIX

About BNT Brookfield Wealth Solutions Ltd.

Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: